$BIIB·4

BIOGEN IDEC INC. · Feb 17, 8:54 PM ET

BIOGEN IDEC INC. 4

4 · BIOGEN IDEC INC. · Filed Feb 17, 2015

Insider Transaction Report

Form 4
Period: 2015-02-12
Holtzman Steven H
EVP Corp Devel and Strategy
Transactions
  • Exercise/Conversion

    Restricted Stock Unit

    2015-02-122,1424,289 total
    Exercise: $0.00Exp: 2017-02-12Common Stock (2,142 underlying)
  • Exercise/Conversion

    Common Stock

    2015-02-12+2,1426,669 total
  • Tax Payment

    Common Stock

    2015-02-12$392.11/sh1,009$395,6395,660 total
  • Exercise/Conversion

    Restricted Stock Unit

    2015-02-121,4925,848 total
    Exercise: $0.00Exp: 2017-02-12Common Stock (1,492 underlying)
  • Other

    Restricted Stock Unit

    2015-02-129544,894 total
    Exercise: $0.00Exp: 2017-02-12Common Stock (954 underlying)
  • Exercise/Conversion

    Common Stock

    2015-02-12+1,4927,152 total
  • Tax Payment

    Common Stock

    2015-02-12$392.11/sh703$275,6536,449 total
Footnotes (3)
  • [F1]The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 150% of the number of shares at target payout. One-fourth of these RSUs are eligible to vest on each of the first four anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average 60 calendar-day closing stock price ending on the vesting date divided by the average 60 calendar-day closing stock price on the grant date]).
  • [F2]The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).
  • [F3]This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT